Phase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia Areata

NCT03532958 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Transfer of study sponsor

Conditions

Alopecia Areata
Alopecia Totalis
Alopecia Universalis

Interventions

DRUG: BNZ-1
DRUG: Normal saline

Sponsor

Equillium